128 related articles for article (PubMed ID: 21121686)
1. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time.
Dudek MM; Kent N; Gustafsson KM; Lindahl TL; Killard AJ
Anal Chem; 2011 Jan; 83(1):319-28. PubMed ID: 21121686
[TBL] [Abstract][Full Text] [Related]
2. Development of a fluorescent method for detecting the onset of coagulation in human plasma on microstructured lateral flow platforms.
Dudek MM; Kent NJ; Gu P; Fan ZH; Killard AJ
Analyst; 2011 May; 136(9):1816-25. PubMed ID: 21293802
[TBL] [Abstract][Full Text] [Related]
3. The uncalibrated prothrombinase-induced clotting time test. Equally convenient but more precise than the aPTT for monitoring of unfractionated heparin.
Korte W; Jovic R; Hollenstein M; Degiacomi P; Gautschi M; Ferrández A
Hamostaseologie; 2010 Nov; 30(4):212-6. PubMed ID: 21057708
[TBL] [Abstract][Full Text] [Related]
4. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
Kurec AS; Morris MW; Davey FR
Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
[TBL] [Abstract][Full Text] [Related]
5. Activated partial thromboplastin time.
Ignjatovic V
Methods Mol Biol; 2013; 992():111-20. PubMed ID: 23546708
[TBL] [Abstract][Full Text] [Related]
6. Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.
Pitney MR; Kelly SA; Allan RM; Giles RW; McCredie M; Walsh WF
Cathet Cardiovasc Diagn; 1996 Feb; 37(2):145-50. PubMed ID: 8808069
[TBL] [Abstract][Full Text] [Related]
7. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
8. The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation.
Ramjee MK
Anal Biochem; 2000 Jan; 277(1):11-8. PubMed ID: 10610684
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
[TBL] [Abstract][Full Text] [Related]
10. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
11. Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assays.
Nurmohamed MT; Berckmans RJ; Morriën-Salomons WM; Berends F; Hommes DW; Rijnierse JJ; Sturk A
Thromb Haemost; 1994 Nov; 72(5):685-92. PubMed ID: 7900075
[TBL] [Abstract][Full Text] [Related]
12. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the new antithrombotic drugs.
Walenga JM; Hoppensteadt DA
Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
Appert-Flory A; Fischer F; Jambou D; Toulon P
Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
[TBL] [Abstract][Full Text] [Related]
15. Standardization and clinical utility of thrombin-generation assays.
Berntorp E; Salvagno GL
Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of activated partial thromboplastin time (aPTT) reagents for application in biomedical diagnostic device development.
Dudek MM; Harris LF; Killard AJ
Int J Lab Hematol; 2011 Jun; 33(3):272-80. PubMed ID: 21118388
[TBL] [Abstract][Full Text] [Related]
17. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protein.
Fiedel BA; Ku CS
Thromb Haemost; 1986 Jun; 55(3):406-9. PubMed ID: 3750270
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative estimation of preanalytical variables which may influence the determinations of prothrombin time (PT) and activated partial thromboplastin time (APTT)].
Isa K; Yamauchi MS; Nago TT; Yamane N
Rinsho Byori; 2010 Oct; 58(10):979-85. PubMed ID: 21077287
[TBL] [Abstract][Full Text] [Related]
20. The activated partial thromboplastin time of diluted plasma: variability due to the method of fibrin detection.
Johnstone IB
Can J Comp Med; 1984 Apr; 48(2):198-201. PubMed ID: 6722646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
